Atom skyrockets after sale of stake to Exame, according to BTG Pactual By Reuters

SAO PAULO (Reuters) – Atom shares soared more than 130% on Wednesday, after Exame, controlled by BTG Pactual (SA :), bought a 34.78% stake in the company, which specializes in publications and teaching materials for the financial market.

After the agreement, WHPH Participações e Empreendimentos, which held 69.569%, will have a share of 34.78%. Within the scope of the transaction, a shareholders’ agreement between WHPH and Exame was also reached, according to a relevant fact earlier on Wednesday.

The shares closed at a high of 131.41%, at 8.84 reais, the best performance of the stock exchange in the session. At the maximum of the session, they reached 10 reais. For comparison, the, which does not have Atom’s roles in the composition, fell 0.18%.

Also related to the business, Atom signed two commercial contracts to take advantage of synergies and business opportunities identified with Exame and BTG Pactual.

In one of them, Exame and Atom will be able to promote campaigns to publicize their respective products, including joint marketing actions. In addition, the company signed a contract with BTG, continuing the partnership currently in force to publicize its RLP (Retail Liquidity Provider) platform and anticipating the potential expansion of the partnership.

(Por Paula Arend Laier)

Risk Disclosure: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.